{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:19:31Z","timestamp":1789517971695,"version":"build-2803163510"},"reference-count":69,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14737167.2026.2691191","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:40:22Z","timestamp":1783582822000},"page":"757-767","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults\u2009\u226565\u2009years of age in Denmark"],"prefix":"10.1080","volume":"26","author":[{"given":"Oluwaseun","family":"Sharomi","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Oidtman","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lang","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tufail","family":"Malik","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Meleleo","sequence":"additional","affiliation":[{"name":"Wolfram Research, Inc","place":["Champaign, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Roesgaard","family":"Kants\u00f8","sequence":"additional","affiliation":[{"name":"MSD Denmark","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Theisen Honore","sequence":"additional","affiliation":[{"name":"MSD Denmark","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Holm Vinfeldt","sequence":"additional","affiliation":[{"name":"MSD Denmark","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Ruth","family":"Flindhardt","sequence":"additional","affiliation":[{"name":"MSD Denmark","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleana","family":"Tsoumani","sequence":"additional","affiliation":[{"name":"MSD Greece","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"e_1_3_7_3_1","unstructured":"European Centre for Disease Prevention (ECDC). Invasive pneumococcal disease - annual epidemiological report for 2022 2022. 2025."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11061376"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2261785"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101271"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01067-1"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011053"},{"key":"e_1_3_7_9_1","unstructured":"Statens Serum Institut. Invasive pneumococcal disease 2018\u20132019 [in Danish]. Available from: https:\/\/en.ssi.dk\/surveillance-and-preparedness\/surveillance-in-denmark\/annual-reports-on-disease-incidence\/i\/invasive-pneumococcal-disease-2018-2019"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000081"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050498"},{"key":"e_1_3_7_12_1","unstructured":"Statens Serum Institut. Pneumococcal vaccination [in Danish]. 2026. Available from: https:\/\/www.ssi.dk\/vaccinationer\/pneumokokvaccination"},{"key":"e_1_3_7_13_1","unstructured":"Statens Serum Institut. Invasive pneumococcal disease - inventory of disease incidence 2020\u201323 [in Danish]. 2024 [cited 2024 May 1]. Available from https:\/\/www.ssi.dk\/sygdomme-beredskab-og-forskning\/sygdomsovervaagning\/i\/invasiv-pneumokoksygdom-opgorelse-over-sygdomsforekomst-2020-23"},{"key":"e_1_3_7_14_1","unstructured":"Statens Serum Institut. Determinants of pneumococccal vaccination of individuals \u226565: April 2020-January 2023 [in Danish]. [cited 2025 Nov 19]. Available from: https:\/\/www.ssi.dk\/-\/media\/arkiv\/dk\/vaccination\/determinantsrapporter\/determinanter-for-pneumokokvaccination_final.pdf"},{"key":"e_1_3_7_15_1","unstructured":"Statens Serum Institut. Pneumococcal vaccination programme for persons aged 65 years or more and for risk groups. [cited 2025 Nov 19]. Available from: https:\/\/en.ssi.dk\/news\/news\/2020\/pneumococcal-vaccination-programme-for-persons-aged-65-years-or-more-and-for-risk-groups"},{"key":"e_1_3_7_16_1","unstructured":"Danish national board of health. Experience gathering - lessons learned from the rollout of seasonal vaccination programs 2022\u20132023 [in Danish]. Danish Health Authority; 2023."},{"key":"e_1_3_7_17_1","unstructured":"Statens Serum Institut. Invasive pneumococcal disease 2020\u20132023 [in Danish]. 2024 [cited 2025 Nov 19]. Available from https:\/\/www.ssi.dk\/aktuelt\/nyhedsbreve\/epi-nyt\/2024\/uge-18-2024"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00344-X"},{"key":"e_1_3_7_19_1","volume-title":"Chapter 8: resistance in human pathogens","author":"The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP)","year":"2024","unstructured":"The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP). Chapter 8: resistance in human pathogens (Kgs. Lyngby and Copenhagen, Denmark: National Food Institute, Technical University of Denmark and Statens Serum Institut). 2024. Available from https:\/\/www.danmap.org\/reports\/2024"},{"key":"e_1_3_7_20_1","unstructured":"European Medicines Agency (EMA). Capvaxive: pneumococcal polysaccharide conjugate vaccine (21-valent) authorization. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/capvaxive"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127080"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7336a3"},{"key":"e_1_3_7_23_1","unstructured":"Statens Serum Institut. Vaccination coverage in Denmark; results from recent reports on influenza COVID and pneumococcal vaccination. 2024 [cited 2025 Nov 19]. Available from: https:\/\/en.ssi.dk\/news\/epi-news\/2024\/no-10-2024"},{"key":"e_1_3_7_24_1","unstructured":"Danish health authority. Vaccine subsidies for individual groups [in Danish]. [cited 2025 Feb 17]. Available from: https:\/\/www.sst.dk\/vidensbase\/forebyggelse\/vaccination\/tilskud-til-vacciner-til-visse-persongrupper"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127940"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03277-3"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.007"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126985"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305892"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-025-01017-z"},{"key":"e_1_3_7_31_1","volume-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2019","unstructured":"World Health Organization WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Geneva: World Health Organization; 2019.","edition":"2"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0335-2"},{"key":"e_1_3_7_33_1","unstructured":"Danmarks Statistik. HISB8: life table by sex age and life table [in Danish]. Available from: https:\/\/www.statistikbanken.dk\/statbank5a\/Selectout\/pivot.asp"},{"key":"e_1_3_7_34_1","unstructured":"Danmarks Statistik. Fertility rates [in Danish]. Available from: https:\/\/www.statistikbanken.dk\/statbank5a\/Selectout\/pivot.asp"},{"key":"e_1_3_7_35_1","unstructured":"Danmarks Statistik. Mortality data [in Danish]. Available from: https:\/\/www.statistikbanken.dk\/statbank5a\/Selectout\/pivot.asp"},{"key":"e_1_3_7_36_1","unstructured":"Statens Serum Institut. The Danish children\u2019s vaccination programme [in Danish]. [cited 2025 Dec 30]. Available from: https:\/\/www.ssi.dk\/vaccinationer\/boernevaccination"},{"key":"e_1_3_7_37_1","unstructured":"Statens Serum Institut. Monitoring in numbers graphs and maps [in Danish]. Copenhagen; 2025]. Available from: https:\/\/statistik.ssi.dk\/"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.05.011"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.01.023"},{"issue":"3","key":"e_1_3_7_42_1","first-page":"170","article-title":"Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial","volume":"72","author":"van Werkhoven CH","year":"2014","unstructured":"van Werkhoven CH, Postma DF, Oosterheert JJ, et al. Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial. Neth J Med. 2014;72(3):170\u2013178.","journal-title":"Neth J Med"},{"key":"e_1_3_7_43_1","volume-title":"Health economics study of vaccines: pneumococcal vaccination of adults [in French]","author":"Beutels P","year":"2017","unstructured":"Haut Conseil de la sant\u00e9 publique (HCSP), Beutels P, Blommaert A, et al. Health economics study of vaccines: pneumococcal vaccination of adults [in French]. Antwerp, Belgium: University of Antwerp; 2017."},{"key":"e_1_3_7_44_1","volume-title":"Invasive pneumococcal disease and PCV coverage 2013 2014","author":"Statens Serum Institut","unstructured":"Statens Serum Institut. Invasive pneumococcal disease and PCV coverage 2013 2014 [updated November 12, 2014; cited 2025 November 19]. Available from https:\/\/en.ssi.dk\/news\/epi-news\/2014\/no-45-2014"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.056"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.04.040"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33583-9"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287581"},{"key":"e_1_3_7_49_1","unstructured":"Statens Serum Institut. 2020."},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072743"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.05.004"},{"key":"e_1_3_7_52_1","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation (ATIH). Plateforme ScanSant\u00e9 [in French]. [2022 Jul 25]. Available from: https:\/\/www.scansante.fr\/applications\/statistiques-activite-MCO-par-GHM"},{"key":"e_1_3_7_53_1","unstructured":"Bpbaw L. Health economics study of vaccines: pneumococcal vaccination of adults [in French]. Universiteit Antwerpen; 2017."},{"key":"e_1_3_7_54_1","unstructured":"Finansministeriet. Guidance on socioeconomic impact assessments [In Danish]. 2023 [cited 2025 Nov 19]. Available from: https:\/\/fm.dk\/udgivelser\/2023\/juni\/vejledning-i-samfundsoekonomiske-konsekvensvurderinger\/"},{"key":"e_1_3_7_55_1","unstructured":"Laegemiddelstyrelsen. Medicinpriser.dk [in Danish]. Available from: https:\/\/www.medicinpriser.dk\/"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283084"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2152235"},{"key":"e_1_3_7_58_1","unstructured":"Danmarks Statistik. Table KAS301: Average number of employees by area (place of work) industry (DB07 36-grp.) socioeconomic status age gender and period 2019 [In Danish]. 2019. Available from: https:\/\/www.statistikbanken.dk\/statbank5a\/selectvarval\/define.asp?PLanguage=0&subword=tabsel&MainTable=KAS301&PXSId=214431&tablestyle=&ST=SD&buttons=0"},{"key":"e_1_3_7_59_1","unstructured":"Danmarks Statistik. Table INDKP201: personal income by income type gender age population price unit and unit 2019 [In Danish]. 2019. Available from: https:\/\/www.statistikbanken.dk\/statbank5a\/selectvarval\/define.asp?PLanguage=0&subword=tabsel&MainTable=INDKP201&PXSId=237243&tablestyle=&ST=SD&buttons=0"},{"key":"e_1_3_7_60_1","unstructured":"Medicinr\u00e5det. Valuation of unit costs [In Danish]. 2023 [cited 2026 Feb 27]. Available from: https:\/\/medicinraadet.dk\/media\/gpjgcotu\/v\u00e6rdis\u00e6tning-af-enhedsomkostninger-vers-1-7.pdf"},{"key":"e_1_3_7_61_1","unstructured":"Danmarks Statistik. Consumer Price Index [in Danish]. 2024. Available from: https:\/\/www.dst.dk\/en\/Statistik\/emner\/oekonomi\/prisindeks\/forbrugerprisindeks"},{"key":"e_1_3_7_62_1","unstructured":"Folkh\u00e4lsomyndigheten. Vaccination against pneumococci \u2013 A health economic evaluation [in Swedish]. 2026 [cited 2026 May 12]. Available from: https:\/\/www.folkhalsomyndigheten.se\/publikationer-och-material\/publikationsarkiv\/v\/vaccination-mot-pneumokocker-en-halsoekonomisk-utvardering\/"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2026.2622857"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01111-8"},{"key":"e_1_3_7_65_1","unstructured":"Statens Serum Institut. Final status: Seasonal vaccination against covid-19 and influenza in 2025 [in Danish]. 2025 [cited 2026 May 12]. Available from: https:\/\/www.sst.dk\/media\/5ozbiqkk\/afsluttende-status-vaccinationsudrulning_2025.pdf"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2024.10.008"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00682-5"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.52225\/narrax.v3i3.230"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060273"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.087"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.24783"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2691191","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:03:07Z","timestamp":1783936987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2691191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14737167.2026.2691191"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2691191","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}